Global English
- Austria Deutsch
- Belgium Nederlands Français
- Brazil Português
- Canada Français English
- France Français
- Germany Deutsch
- Ireland English
- Italy Italiano
- Japan 日本語
- Luxembourg Français Deutsch
- Netherlands Nederlands
- Portugal Português
- Spain Español
- Switzerland Français Deutsch Italiano
- Taiwan 繁體中文
- United Kingdom English

Corporate Social Responsibility

Alnylam 2023 corporate responsibility Report

May 7, 2024 Alnylam Publishes 2023 Corporate Responsibility Report Alnylam's 2023 Corporate Responsibility Report details our corporate responsibility and ESG efforts and progress. Read More ›

Alnylam 2023 Patient Access Philosophy Report

April 25, 2024 Our Commitment to Patients Means Never Stop Evolving - Our Patient Access Philosophy Tolga Tanguler, Alnylam's Chief Commercial Officer discusses Alnylam's Patient Access Philosophy and approach to access Read More ›

Subscribe to Corporate Social Responsibility

You are now leaving Alnylam.com

The following content may not be associated with Alnylam Pharmaceuticals.

Links to all outside sites are provided as a reference for our visitors.

Alnylam Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by Alnylam Pharmaceuticals.

Proceed to Site